Starton Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2017-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.startontx.com
Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Lenalidomide in Multiple Myeloma (MM)
- First Posted Date
- 2023-10-18
- Last Posted Date
- 2023-10-18
- Lead Sponsor
- Starton Therapeutics, Inc
- Target Recruit Count
- 6
- Registration Number
- NCT06087653
- Locations
- 🇺🇸
Gabrail Cancer & Research Center, Canton, Ohio, United States
© Copyright 2025. All Rights Reserved by MedPath